These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 27666789)

  • 1. Pretreatment with a γ-Secretase Inhibitor Prevents Tumor-like Overgrowth in Human iPSC-Derived Transplants for Spinal Cord Injury.
    Okubo T; Iwanami A; Kohyama J; Itakura G; Kawabata S; Nishiyama Y; Sugai K; Ozaki M; Iida T; Matsubayashi K; Matsumoto M; Nakamura M; Okano H
    Stem Cell Reports; 2016 Oct; 7(4):649-663. PubMed ID: 27666789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-evaluated safe human iPSC-derived neural stem cells promote functional recovery after spinal cord injury in common marmoset without tumorigenicity.
    Kobayashi Y; Okada Y; Itakura G; Iwai H; Nishimura S; Yasuda A; Nori S; Hikishima K; Konomi T; Fujiyoshi K; Tsuji O; Toyama Y; Yamanaka S; Nakamura M; Okano H
    PLoS One; 2012; 7(12):e52787. PubMed ID: 23300777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with a Gamma-Secretase Inhibitor Promotes Functional Recovery in Human iPSC- Derived Transplants for Chronic Spinal Cord Injury.
    Okubo T; Nagoshi N; Kohyama J; Tsuji O; Shinozaki M; Shibata S; Kase Y; Matsumoto M; Nakamura M; Okano H
    Stem Cell Reports; 2018 Dec; 11(6):1416-1432. PubMed ID: 30503258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo monitoring of remnant undifferentiated neural cells following human induced pluripotent stem cell-derived neural stem/progenitor cells transplantation.
    Tanimoto Y; Yamasaki T; Nagoshi N; Nishiyama Y; Nori S; Nishimura S; Iida T; Ozaki M; Tsuji O; Ji B; Aoki I; Jinzaki M; Matsumoto M; Fujibayashi Y; Zhang MR; Nakamura M; Okano H
    Stem Cells Transl Med; 2020 Apr; 9(4):465-477. PubMed ID: 31904914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlling immune rejection is a fail-safe system against potential tumorigenicity after human iPSC-derived neural stem cell transplantation.
    Itakura G; Kobayashi Y; Nishimura S; Iwai H; Takano M; Iwanami A; Toyama Y; Okano H; Nakamura M
    PLoS One; 2015; 10(2):e0116413. PubMed ID: 25706286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LOTUS overexpression via ex vivo gene transduction further promotes recovery of motor function following human iPSC-NS/PC transplantation for contusive spinal cord injury.
    Ito S; Nagoshi N; Kamata Y; Kojima K; Nori S; Matsumoto M; Takei K; Nakamura M; Okano H
    Stem Cell Reports; 2021 Nov; 16(11):2703-2717. PubMed ID: 34653401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rehabilitative Training Enhances Therapeutic Effect of Human-iPSC-Derived Neural Stem/Progenitor Cells Transplantation in Chronic Spinal Cord Injury.
    Shibata T; Tashiro S; Shibata S; Shinozaki M; Shindo T; Hashimoto S; Kawai M; Kitagawa T; Ago K; Matsumoto M; Nakamura M; Okano H; Nagoshi N
    Stem Cells Transl Med; 2023 Mar; 12(2):83-96. PubMed ID: 36647673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective Ablation of Tumorigenic Cells Following Human Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cell Transplantation in Spinal Cord Injury.
    Kojima K; Miyoshi H; Nagoshi N; Kohyama J; Itakura G; Kawabata S; Ozaki M; Iida T; Sugai K; Ito S; Fukuzawa R; Yasutake K; Renault-Mihara F; Shibata S; Matsumoto M; Nakamura M; Okano H
    Stem Cells Transl Med; 2019 Mar; 8(3):260-270. PubMed ID: 30485733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. γ-secretase inhibitors prevent overgrowth of transplanted neural progenitors derived from human-induced pluripotent stem cells.
    Ogura A; Morizane A; Nakajima Y; Miyamoto S; Takahashi J
    Stem Cells Dev; 2013 Feb; 22(3):374-82. PubMed ID: 23020188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term selective stimulation of transplanted neural stem/progenitor cells for spinal cord injury improves locomotor function.
    Kawai M; Imaizumi K; Ishikawa M; Shibata S; Shinozaki M; Shibata T; Hashimoto S; Kitagawa T; Ago K; Kajikawa K; Shibata R; Kamata Y; Ushiba J; Koga K; Furue H; Matsumoto M; Nakamura M; Nagoshi N; Okano H
    Cell Rep; 2021 Nov; 37(8):110019. PubMed ID: 34818559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the immunogenicity of human iPS cell-derived neural stem/progenitor cells in vitro.
    Ozaki M; Iwanami A; Nagoshi N; Kohyama J; Itakura G; Iwai H; Nishimura S; Nishiyama Y; Kawabata S; Sugai K; Iida T; Matsubayashi K; Isoda M; Kashiwagi R; Toyama Y; Matsumoto M; Okano H; Nakamura M
    Stem Cell Res; 2017 Mar; 19():128-138. PubMed ID: 28135684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fail-Safe System against Potential Tumorigenicity after Transplantation of iPSC Derivatives.
    Itakura G; Kawabata S; Ando M; Nishiyama Y; Sugai K; Ozaki M; Iida T; Ookubo T; Kojima K; Kashiwagi R; Yasutake K; Nakauchi H; Miyoshi H; Nagoshi N; Kohyama J; Iwanami A; Matsumoto M; Nakamura M; Okano H
    Stem Cell Reports; 2017 Mar; 8(3):673-684. PubMed ID: 28262544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplantation of neural stem/progenitor cells at different locations in mice with spinal cord injury.
    Iwai H; Nori S; Nishimura S; Yasuda A; Takano M; Tsuji O; Fujiyoshi K; Toyama Y; Okano H; Nakamura M
    Cell Transplant; 2014; 23(11):1451-64. PubMed ID: 23998989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of remyelination by neural stem/progenitor cells transplanted into the injured spinal cord.
    Yasuda A; Tsuji O; Shibata S; Nori S; Takano M; Kobayashi Y; Takahashi Y; Fujiyoshi K; Hara CM; Miyawaki A; Okano HJ; Toyama Y; Nakamura M; Okano H
    Stem Cells; 2011 Dec; 29(12):1983-94. PubMed ID: 22028197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal properties of iPSC-derived neural progenitors that generate undesired grafts after transplantation.
    Isoda M; Sanosaka T; Tomooka R; Mabuchi Y; Shinozaki M; Andoh-Noda T; Banno S; Mizota N; Yamaguchi R; Okano H; Kohyama J
    Commun Biol; 2023 Jun; 6(1):611. PubMed ID: 37286713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-Genome DNA Methylation Analyses Revealed Epigenetic Instability in Tumorigenic Human iPS Cell-Derived Neural Stem/Progenitor Cells.
    Iida T; Iwanami A; Sanosaka T; Kohyama J; Miyoshi H; Nagoshi N; Kashiwagi R; Toyama Y; Matsumoto M; Nakamura M; Okano H
    Stem Cells; 2017 May; 35(5):1316-1327. PubMed ID: 28142229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safe and efficient method for cryopreservation of human induced pluripotent stem cell-derived neural stem and progenitor cells by a programmed freezer with a magnetic field.
    Nishiyama Y; Iwanami A; Kohyama J; Itakura G; Kawabata S; Sugai K; Nishimura S; Kashiwagi R; Yasutake K; Isoda M; Matsumoto M; Nakamura M; Okano H
    Neurosci Res; 2016 Jun; 107():20-9. PubMed ID: 26804710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A robust culture system to generate neural progenitors with gliogenic competence from clinically relevant induced pluripotent stem cells for treatment of spinal cord injury.
    Kamata Y; Isoda M; Sanosaka T; Shibata R; Ito S; Okubo T; Shinozaki M; Inoue M; Koya I; Shibata S; Shindo T; Matsumoto M; Nakamura M; Okano H; Nagoshi N; Kohyama J
    Stem Cells Transl Med; 2021 Mar; 10(3):398-413. PubMed ID: 33226180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation by DREADD reveals the therapeutic effect of human iPSC-derived neuronal activity on functional recovery after spinal cord injury.
    Kitagawa T; Nagoshi N; Kamata Y; Kawai M; Ago K; Kajikawa K; Shibata R; Sato Y; Imaizumi K; Shindo T; Shinozaki M; Kohyama J; Shibata S; Matsumoto M; Nakamura M; Okano H
    Stem Cell Reports; 2022 Jan; 17(1):127-142. PubMed ID: 35021049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human-induced pluripotent stem cell-derived neural stem/progenitor cell ex vivo gene therapy with synaptic organizer CPTX for spinal cord injury.
    Saijo Y; Nagoshi N; Kawai M; Kitagawa T; Suematsu Y; Ozaki M; Shinozaki M; Kohyama J; Shibata S; Takeuchi K; Nakamura M; Yuzaki M; Okano H
    Stem Cell Reports; 2024 Mar; 19(3):383-398. PubMed ID: 38366597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.